PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 61 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $11,633,000 | +25.2% | 482,680 | 0.0% | 1.99% | +17.7% |
| Q1 2017 | $9,292,000 | +25.0% | 482,680 | 0.0% | 1.69% | -2.1% |
| Q4 2016 | $7,433,000 | +18.4% | 482,680 | 0.0% | 1.73% | +33.5% |
| Q3 2016 | $6,280,000 | -6.5% | 482,680 | 0.0% | 1.29% | -18.4% |
| Q2 2016 | $6,714,000 | -35.2% | 482,680 | -29.3% | 1.59% | -23.5% |
| Q1 2016 | $10,356,000 | -20.0% | 682,680 | 0.0% | 2.07% | -7.1% |
| Q4 2015 | $12,950,000 | -0.2% | 682,680 | 0.0% | 2.23% | -2.1% |
| Q3 2015 | $12,971,000 | -26.3% | 682,680 | 0.0% | 2.28% | -13.0% |
| Q2 2015 | $17,593,000 | -17.6% | 682,680 | 0.0% | 2.62% | -6.2% |
| Q1 2015 | $21,341,000 | -18.9% | 682,680 | 0.0% | 2.79% | -30.0% |
| Q4 2014 | $26,317,000 | – | 682,680 | – | 3.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $13,340,000 | 9.89% |
| Abingworth LLP | 1,041,131 | $5,341,000 | 4.85% |
| Roumell Asset Management, LLC | 450,406 | $2,311,000 | 4.78% |
| HIGHLAND CAPITAL MANAGEMENT LP | 2,391,993 | $12,271,000 | 0.94% |
| Trellus Management Company, LLC | 71,200 | $365,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 1,968,000 | $10,096,000 | 0.76% |
| Arbiter Partners Capital Management LLC | 1,111,936 | $5,704,000 | 0.64% |
| Fortress Investment Group LLC | 433,804 | $2,226,000 | 0.27% |
| GENERAL AMERICAN INVESTORS CO INC | 464,985 | $2,385,000 | 0.25% |
| WATER ISLAND CAPITAL LLC | 318,518 | $1,634,000 | 0.12% |